Column Capital Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,450
Closed -$87.8K – 817
2023
Q2
$107K Hold
1,450
– – 0.02% 213
2023
Q1
$85.1K Hold
1,450
– – 0.01% 249
2022
Q4
$73.1K Hold
1,450
– – 0.01% 246
2022
Q3
$126K Hold
1,450
– – 0.03% 163
2022
Q2
$165K Hold
1,450
– – 0.03% 129
2022
Q1
$188K Hold
1,450
– – 0.03% 134
2021
Q4
$262K Sell
1,450
-240
-14% -$41.6K 0.05% 104
2021
Q3
$251K Hold
1,690
– – 0.05% 107
2021
Q2
$256K Hold
1,690
– – 0.05% 104
2021
Q1
$219K Hold
1,690
– – 0.05% 112
2020
Q4
$203K Sell
1,690
-110
-6% -$10.8K 0.05% 104
2020
Q3
$134K Hold
1,800
– – 0.04% 130
2020
Q2
$127K Sell
1,800
-200
-10% -$13.7K 0.04% 128
2020
Q1
$131K Sell
2,000
-200
-9% -$15.9K 0.05% 97
2019
Q4
$179K Buy
+2,200
New +$169K 0.09% 99

Other funds holding OMCL

Column Capital Advisors's OMCL Position: Q3 2023 in Review

Column Capital Advisors sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 1,450 shares — an estimated $87.8K sold.

Column Capital Advisors first reported a position in OMCL in Q4 2019 and held it in 15 quarters. The position peaked at $262K in Q4 2021. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.

  • Column Capital Advisors reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
  • Column Capital Advisors sold 1,450 Omnicell shares in Q3 2023, an estimated $87.8K.
  • Column Capital Advisors first reported a position in Omnicell in Q4 2019 and held it in 15 quarters.
  • Column Capital Advisors's Omnicell position peaked at $262K in Q4 2021.
  • 312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.